![Prevention of episodic migraine with topiramate: a prospective 24-week, open-label, flexible-dose clinical trial with optional 24 weeks follow-up in a community setting]()
Prevention of episodic migraine with topiramate: a prospective 24-week, open-label, flexible-dose clinical trial with optional 24 weeks follow-up in a community settingMalessa, R.; Gendolla, A.; Steinberg, B.; Schmitt, L.; Bornhoevd, K.; Djelani, M.; Schäuble, B. · Current Medical Research and Opinion · 2010